comparemela.com

Latest Breaking News On - அமெரிக்கன் கல்லூரி ஆஃப் மருத்துவ ஜெநெடிக்ஸ் - Page 10 : comparemela.com

Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting

Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting BOSTON, April 08, 2021 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases of abnormal mineralization, today announced that data from the burden of illness in infantile onset ABCC6 and ENPP1 deficiency study will be presented at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting taking place April 13-16, 2021. The following poster presentation will be available during the ACMG Annual Clinical Genetics Meeting beginning on Wednesday, April 14, 2021, at 7:00 a.m. ET:

Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Adequate reimbursement for molecular diagnostic tests can improve patient care

Adequate reimbursement for molecular diagnostic tests can improve patient care The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the results of its qualitative and quantitative Analysis of Professional Work Effort in Molecular Test Interpretation Report. More than 100 molecular professionals from the AMP and American College of Medical Genetics and Genomics (ACMG) communities reported that their efforts spent on data analysis, interpretation, and reporting for molecular diagnostic tests were not sufficiently reimbursed. Respondents indicated that adequate reimbursement for these activities would improve patient care by increasing access to these essential medical services and enabling more data-driven treatment decisions.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.